Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 22 February, 2024|Author: Getaka | Social: X Twitter Profile

Fundamental Analysis of Shilpa Medicare Ltd

About the Company - Shilpa Medicare Ltd

Shilpa Medicare Ltd. is a Public Limited Listed company incorporated on 20/11/1987 and has its registered office in the State of Karnataka, India. Company’s Corporate Identification Number(CIN) is L85110KA1987PLC008739 and registration number is 008739. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 356.95 Cr. and Equity Capital is Rs. 8.68 Cr. for the Year ended 31/03/2022.
INDUSTRYADDRESSCONTACT
Pharmaceuticals# 12-6-214/A-1, Shilpa House, Raichur Karnataka 584135info@vbshilpa.com
http://www.vbshilpa.com
Management
NamePosition Held
Mr. Omprakash InaniChairman
Mr. Vishnukant Chaturbhuj BhutadaManaging Director
Mr. Sharath Reddy KalakotaWhole Time Director
Ms. Sirisha ChintapalliIndependent Woman Director
Mr. Hetal Madhukant GandhiIndependent Director
Mr. Arvind VasudevaIndependent Director
Dr. Kamal K SharmaIndependent Director
Dr. Anita BandyopadhyayIndependent Director

Shilpa Medicare Ltd. Share Price Update

Share PriceValue
Today₹370.85
Previous Day₹383.75

Basic Stock Data of Shilpa Medicare Ltd

Market Cap 3,889 Cr.
Current Price 448
High / Low457/222
Stock P/E
Book Value 205
Dividend Yield0.00 %
ROCE0.81 %
ROE1.71 %
Face Value 1.00

Data Source: screener.in

Competitors of Shilpa Medicare Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Vivimed Labs Ltd 41.0 Cr. 4.958.16/4.85 21.30.00 %51.5 %163 % 2.00
Natco Pharma Ltd 18,412 Cr. 1,0281,108/52014.4 2960.92 %17.7 %15.3 % 2.00
Aarey Drugs & Pharmaceuticals Ltd 124 Cr. 49.068.0/21.929.5 46.80.00 %6.38 %3.33 % 10.0
Glaxosmithkline Pharmaceuticals Ltd 38,658 Cr. 2,2822,650/1,22760.3 90.91.38 %36.4 %26.8 % 10.0
Nectar Lifescience Ltd 927 Cr. 41.345.7/14.4114 47.60.00 %0.18 %6.01 % 1.00
Industry Average229.6 Cr19.6543.64100.520.46%22.43%42.89%5

Shilpa Medicare Ltd Quarterly Results

MonthSep 2020Dec 2020Mar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023
Sales278.94191.25208.03237.36295.27272.30340.60261.16262.91262.50263.56260.17312.98
Expenses210.29170.75182.19206.22243.25227.97267.87241.32252.91231.22226.54213.91254.59
Operating Profit68.6520.5025.8431.1452.0244.3372.7319.8410.0031.2837.0246.2658.39
OPM %24.61%10.72%12.42%13.12%17.62%16.28%21.35%7.60%3.80%11.92%14.05%17.78%18.66%
Other Income9.208.616.911.9910.195.485.378.104.393.072.171.931.81
Interest3.954.809.1210.3211.589.929.359.5913.4717.8517.7418.1523.24
Depreciation12.7013.7215.2317.6319.1820.6522.3422.4223.3124.0825.6926.7527.79
Profit before tax61.2010.598.405.1831.4519.2446.41-4.07-22.39-7.58-4.243.299.17
Tax %26.14%27.48%9.52%68.73%36.76%50.47%36.33%157.74%17.06%12.66%-90.09%64.44%82.88%
Net Profit45.217.677.611.6219.899.5429.552.34-18.58-6.62-8.051.181.57
EPS in Rs5.570.940.960.202.451.103.400.10-2.15-0.76-0.930.140.19

Shilpa Medicare Ltd Quarterly Chart

Shilpa Medicare Ltd Profit & Loss

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023TTM
Sales3183715716147197797897339088991,1411,0461,099
Expenses258301455485566614634585688718940947926
Operating Profit617011612915316515514821918120299173
OPM %19%19%20%21%21%21%20%20%24%20%18%9%16%
Other Income105655152233179021179
Interest22447334522415977
Depreciation141523212931374244548096104
Profit before tax535795108122146137136188195102-381
Tax %23%17%21%33%19%29%25%19%18%25%41%19%
Net Profit414775739910410311015514661-31-12
EPS in Rs5.616.4410.289.5613.4613.4312.9113.7719.1518.136.99-3.74-1.36
Dividend Payout %5%7%5%6%4%4%5%7%6%6%16%0%

Shilpa Medicare Ltd Profit & Loss Yearly Chart

Shilpa Medicare Ltd Growth

Compounded Sales Growth
10 Years:11%
5 Years:6%
3 Years:5%
TTM:0%
Compounded Profit Growth
10 Years:%
5 Years:%
3 Years:%
TTM:-113%
Stock Price CAGR
10 Years:10%
5 Years:5%
3 Years:7%
1 Year:62%
Return on Equity
10 Years:8%
5 Years:5%
3 Years:3%
Last Year:-2%

Shilpa Medicare Ltd Balance Sheet

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Sep 2023
Equity Capital5578888888999
Reserves2713163895396399791,0771,1891,3211,4711,8141,7751,775
Borrowings61132118189221241191194390846683798865
Other Liabilities9699163169194244223218270308370321355
Total Liabilities4335516789051,0621,4721,4991,6101,9892,6322,8762,9023,004
Fixed Assets1671812943165804925345586501,1111,3421,3681,653
CWIP5812911122295141210429666541506655389
Investments685010665325314021021344345
Other Assets141191262301334587615621662959993836917
Total Assets4335516789051,0621,4721,4991,6101,9892,6322,8762,9023,004

Shilpa Medicare Ltd Reserves and Borrowings Chart

Shilpa Medicare Ltd Cash Flow

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Cash from Operating Activity 57447069129374514712447105226
Cash from Investing Activity -152-95-49-196-106-257-10-196-290-404-286-278
Cash from Financing Activity 1066-28136-20313-61101764368346
Net Cash Flow-8615-89393-26-391079-98-7

Shilpa Medicare Ltd Financial Efficiency Indicators

MonthMar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023
Debtor Days4741434843801021019988124113
Inventory Days134126143147161187194266298427338281
Days Payable99871088510111010611512291139127
Cash Conversion Cycle828079111104157189253275425323267
Working Capital Days6081506764122144141134222182164
ROCE %18%15%20%18%16%14%10%9%12%8%6%1%

Shilpa Medicare Ltd Financial Efficiency Indicators Chart

Shilpa Medicare Ltd Share Holding Pattern

MonthMar 2021Jun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
Promoters53.25%53.25%53.25%50.01%50.01%50.01%50.01%50.01%50.01%50.01%50.01%50.01%
FIIs16.23%14.56%12.27%14.59%14.41%14.41%14.46%15.32%13.73%10.26%8.60%8.52%
DIIs4.41%3.52%2.91%2.86%1.93%1.99%1.76%0.61%0.54%0.37%0.41%0.06%
Public26.12%28.68%31.57%32.54%33.65%33.59%33.78%34.04%35.72%39.36%40.98%41.41%
No. of Shareholders51,27753,22046,54039,56539,72439,09741,57946,14346,86950,43444,09443,630

Shilpa Medicare Ltd Shareholding Pattern Chart

No. of Shilpa Medicare Ltd Shareholders

Shilpa Medicare Ltd Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)
Motilal Oswal Nifty Microcap 250 Index Fund489030.261.62
Motilal Oswal S&P BSE Healthcare ETF4050.140.01

Shilpa Medicare Ltd ROCE Trend

Shilpa Medicare Ltd EPS Trend

Shilpa Medicare Ltd Key Financial Ratios

MonthMar 23Mar 22Mar 21Mar 20Mar 19
FaceValue1.001.001.001.001.00
Basic EPS (Rs.)-3.747.2618.1319.1513.77
Diluted EPS (Rs.)-3.747.2618.1319.1513.77
Cash EPS (Rs.)7.8816.5924.7724.3719.57
Book Value[Excl.RevalReserv]/Share (Rs.)204.41208.65180.00162.09145.96
Book Value[Incl.RevalReserv]/Share (Rs.)204.41208.65180.00162.09145.96
Revenue From Operations / Share (Rs.)120.98131.97110.53111.3689.96
PBDIT / Share (Rs.)13.7925.1325.9829.0420.80
PBIT / Share (Rs.)2.7915.9319.3623.6715.64
PBT / Share (Rs.)-3.9712.2024.1423.1117.63
Net Profit / Share (Rs.)-3.127.4018.1519.0014.41
NP After MI And SOA / Share (Rs.)-3.746.9918.1319.1513.77
PBDIT Margin (%)11.3919.0323.5026.0723.11
PBIT Margin (%)2.3012.0717.5121.2517.38
PBT Margin (%)-3.289.2421.8320.7519.59
Net Profit Margin (%)-2.585.6016.4117.0616.02
NP After MI And SOA Margin (%)-3.095.2916.3917.1915.30
Return on Networth / Equity (%)-1.823.329.9911.749.37
Return on Capital Employeed (%)1.146.107.7512.229.39
Return On Assets (%)-1.112.105.607.866.97
Long Term Debt / Equity (X)0.160.190.320.120.06
Total Debt / Equity (X)0.440.370.480.240.14
Asset Turnover Ratio (%)0.360.120.360.440.41
Current Ratio (X)0.981.451.521.522.15
Quick Ratio (X)0.570.860.990.961.41
Inventory Turnover Ratio (X)1.100.351.161.401.30
Dividend Payout Ratio (NP) (%)0.0014.780.0013.210.00
Dividend Payout Ratio (CP) (%)0.006.380.0010.320.00
Earning Retention Ratio (%)0.0085.220.0086.790.00
Cash Earning Retention Ratio (%)0.0093.620.0089.680.00
Interest Coverage Ratio (X)2.045.309.6851.9446.13
Interest Coverage Ratio (Post Tax) (X)0.532.354.9834.9927.57
Enterprise Value (Cr.)2756.044084.093310.972271.152839.07
EV / Net Operating Revenue (X)2.623.573.672.503.87
EV / EBITDA (X)23.0318.7315.639.5916.74
MarketCap / Net Operating Revenue (X)1.903.013.022.203.78
Retention Ratios (%)0.0085.210.0086.780.00
Price / BV (X)1.121.891.841.502.32
Price / Net Operating Revenue (X)1.903.013.022.203.78
EarningsYield-0.010.010.050.070.04

Shilpa Medicare Ltd Profitability Ratios (%)

Shilpa Medicare Ltd Liquidity Ratios

Shilpa Medicare Ltd Liquidity Ratios (%)

Shilpa Medicare Ltd Interest Coverage Ratios (X)

Shilpa Medicare Ltd Valuation Ratios

Fair Value / Intrinsic Value of Shilpa Medicare Ltd

Fair Value: ₹53.63

The stock is overvalued by 88.03% compared to the current price ₹448

*Investments are subject to market risks

Strength and Weakness of Shilpa Medicare Ltd

StrengthWeakness
  1. The company has higher reserves (1,042.69 cr) compared to borrowings (379.15 cr), indicating strong financial stability.
  2. The company has shown consistent growth in sales (515.69 cr) and profit (100.15 cr) over the years.
  1. The stock is trading at a high valuation with an average P/B ratio of 15.48 and average Dividend Yield of 14.10%.
  2. The stock has a low average ROCE of 12.25%, which may not be favorable.
  3. The stock has a high average Working Capital Days of 119.25, which may not be favorable.
  4. The stock has a high average Cash Conversion Cycle of 195.42, which may not be favorable.

Should I Buy Shilpa Medicare Ltd Share Now?

  • Considering various financial indicators, investors might exercise caution regarding investment in Shilpa Medicare Ltd:
    1. Net Profit Margin: -2.58%
      • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
    2. ROCE: 1.14% (Industry Average ROCE: 24.7%)
      • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
    3. Interest Coverage Ratio (Post Tax): 0.53
      • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
    4. Quick Ratio: 0.57
      • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
    5. ✓ Stock P/E of N/A (Industry average Stock P/E: 82.72)
      • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
    6. ✓ Total Debt / Equity: 0.44
      • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
    The current analysis suggests exercising caution. It's advisable to conduct further research or consult with financial experts before considering any investment.

About the Author

Author Avatar
Getaka

Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Shilpa Medicare Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE